Return to: Department of Medicine : Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Whats Inside
Center for Lung Science and Health

Conferences

Contact Us

Faculty

Fellowship Program

Make a Gift

NHLBI Training Grant Program

Outpatient Clinic Information

Recent Achievements

Research

 

PACCHome

Home > Faculty > Michael Alter, MD

Printer-friendly version   Mail this page to a friend

Michael Alter, MD


Dr. Alter Assistant Professor of Medicine
Board Certifications:  Internal Medicine,
Pulmonary Medicine, Critical Care Medicine


Dr. Alter, originally from Ohio, graduated from the Ohio State University with a B.S. in microbiology in 1989 and received his M.D. from Medical College of Ohio (now Medical University of Ohio) in 1994. He spent 1 year of internship training at Metrohealth Medical Center in Cleveland, Ohio before transferring to the University of Minnesota to complete his residency training in 1997. Dr. Alter completed his fellowship training in Pulmonary and Critical Care Medicine at the University of Minnesota in 2000 and spent the following year doing laboratory research at the VA Medical Center.

After 4 years in private practice, he returned to the University of Minnesota in 2005 to pursue his clinical interest in sleep disorders and general pulmonary medicine.

Recent Publications:

Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination.  Rubins JB, Alter M, Loch J, Janoff EN.  Infection and Immunity6(11), 5979-5984, 1999.

Inhibition of non-small cell lung cancer growth by doxycycline.  Alter M, Rubins JB, Chest. 116(4, supp. 2), 1999.

Options in therapeutic anticoagulatoin for the treatment of venous thromboembolic disease.  Yacovella T, Alter MPost-Graduate Medicine, 108(4), 2000.

Inhibition of mesothelioma cell growth in vitro by doxycycline.  Rubins JB, Charboneau D, Alter M, Bitterman PB, Kratzke RA.   J Lab and Clin Med 138(2):101-106, 2001.

Repression of Cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo.  Jacobson VA, Alter MD, Kratzke MG, Frizelle SP, Zhang Y, Peterson MS, Avdulov, S, Mohorn RP, Whitson BA, Bitterman PB, Polunovsky VA, Kratzke RA.  Cancer Research 55, 4256-4262, 2006.

Last updated 10/10/2007


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.